1. HOME
2. Research Insight
3. Sysmex Corporation (Japan) and Danaher Corporation (US) are Leading Players in the Hematology Analyzers and Reagents Market

The global hematology analyzers and reagents market is projected to reach USD 8.8 billion by 2029 from USD 6.6 billion in 2024, at a CAGR of 6.1% from 2024 to 2029. The rising technological advancements, increasing incidence of blood disorders, growing number of blood donations and integration of hematology analyzers with flow cytometry. These key factors are encouraging the growth of hematology analyzers and reagents market globally.

The hematology analyzers and reagents market exhibits moderate competitiveness, featuring both established companies and emerging competitors for the same market share. As of 2023, the key players operating in the global hematology analyzers and reagents market are Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden Corporation (Japan), Siemens Healthineers (Germany), Abbott Laboratories (US), Boule Diagnostics AB (Sweden), Horiba, Ltd. (Japan), Bio-Rad Laboratories Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd.  (China) and F. Hoffmann-La Roche Ltd. (Switzerland).

To know about the assumptions considered for the study download the pdf brochure

In the past four years, top players in this market have employed key strategies such as product and service launches, making agreements, and undertaking expansions. In 2023, a major share of the hematology analyzers and reagents market was held by Sysmex Corporation (Japan), Danaher Corporation (US) and Siemens Healthineers (Germany), Abbott Laboratories (US) and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.  (China).

Sysmex Corporation (Japan)

Sysmex is one of the leading technology and manufacturing product-based companies. The company is involved in developing and manufacturing analyzers and reagents for hematology and hemostasis solutions. The company offers instruments, reagents and maintenance services. Sysmex operates in more than 40 countries across the world’s major markets, including North America, Latin America, Europe, the Asia Pacific, the Middle East, and Africa. The company’s export service is spread in more than 190 countries. The company operates its global business through its subsidiaries, including RIKEN GENESIS (Japan), Sysmex America, Sysmex Europe, Sysmex Asia Pacific, Sysmex Shanghai (China), Sysmex Polska, Sysmex (Malaysia) Sdn Bhd, Sysmex (Thailand). The company focuses on strengthening its market share and expanding its revenue base in the hematology analyzers and reagents segment by expanding its product portfolio through product launches & enhancements. Sysmex Corporation is also involved in collaborations with key stakeholders to enhance its R&D capabilities and increase public awareness of its hematology analyzers and reagents products across the world’s major markets.

Danaher Corporation (US)

Danaher Corporation holds a significant share in the global hematology analyzers and reagents market. The company offers an extensive range of hematology products for the blood analysis. To maintain its market position and ensure future growth, the company focuses primarily on acquisitions and partnerships. Danaher focuses on its R&D to provide its customers with innovative products and maintain its competitive position in the market. The company’s efforts to strengthen its product portfolio, expand its geographic reach, and increase brand visibility are expected to drive its growth in the hematology analyzers and reagents market.

Abbott Laboratories (US)

Abbott is a global innovation company that focuses on innovation and product launches in the field of hematology analysers and reagents to provide advanced solutions to industry professionals to analysis blood. The Core Laboratory segment (a subsegment of the Diagnostics business segment) of the company offers a broad range of hematology analyzers and reagents.

Abbott primarily pursues the strategy of product launches to sustain its position in the global hematology analysers and reagents market. Extensive product portfolio and technological advancements in its analysers are expected to help the company maintain its leadership position in the hematology analysers and reagents market.

The company is mainly dependent on the US for revenue generation; in FY 2023, around 39% of the company’s total revenue came from the US.

Siemens Healthineers (US)

Siemens Healthineers is one of the significant player in the market, known for integrating advanced technology into their hematology analyzers. The company offers a wide range of hematology analyzers and reagents through it Diagnostics segment. Their devices are designed to provide accurate, reliable, and fast results, which are crucial for effective patient care. This versatility allows them to serve a broad market segment. Siemens Healthineers have a strong global presence helping the company to reach a wide customer base. Their products are available in many regions around the world due to their extensive distribution network.

Siemens Healthineers focuses on technological advancement using Artificial intelligence (AI). In the portfolio of hematology products and services, the company successfully employs AI for data analysis and interpretation, decision-making, intelligent robot control, and automation.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)

Mindray has established itself as a key competitor in hematology analyzers and reagents market amongst the other major competitor companies. The company is renowned for incorporating cutting-edge technology into their hematology analyzers. Their devices often feature advanced automation, accurate data processing, and user-friendly interfaces. Furthermore, the company offers robust customer support and training programs, ensuring that healthcare professionals can effectively utilize their hematology analyzers and reagents.

Mindray sells its products across 190 countries. The company operates a distribution and service network with subsidiaries in over 32 countries across North and Latin America, Europe, Africa, and the Asia Pacific.

Related Reports:

Hematology Analyzers and Reagents Market by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price (High, Mid, Low), Application (Anemia, Blood Cancer), End User (Hospital, CTL, Govt Lab, Blood Bank) - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]